Prevalence and Otorhinological Symptoms of People with COVID-19 in Rivers State: A Prospective Descriptive Study | Chapter 15 | Current Practice in Medical Science Vol. 6

Coronavirus disease 2019 (COVID-19) has rapidly crossed all international borders and spread over the entire planet. Lower respiratory tract symptoms as fever, coughing, dyspnea, and tightness in the chest predominately define it. On the other hand, COVID-19 results in symptoms of the upper respiratory tract like nasal congestion, sore throat, and olfactory impairment. Therefore, the goal of this study was to evaluate the prevalence and ENT/otorhinolaryngologic (ENT) symptomatology of COVID-19 patients in Rivers State. All Rivers State hospital patients with COVID-19 designation who gave their consent to participate in the study were the subject of a prospective descriptive analysis. 2223 samples were collected overall, of which 137 (6.16 percent) were symptomatic and 2086 (93.84 percent) were asymptomatic, according to the Nigerian protocol for sample collection and PCR diagnosis for SARS COV-2. Age, sex, the day the symptoms started, and the day the sample was collected were all noted. According to the NCDC's guidelines, a diagnosis of COVID-19 infection was made using multiplex RT-PCR and Gene Finder by Osang Korea. Out of a total of 2223 patients evaluated, the results showed that 206 had positive COVID-19 results, whereas 2017 (91 percent) had negative results. As asymptomatic patients carry COVID-19 infections and place a significant burden on healthcare systems, the study shows that COVID-19 prevalence among symptomatic and asymptomatic patients in the study area is considerable and of epidemiologic concern. The study also showed that the main symptom of Covid 19 is ENT syndrome.

 

Author (s) Details

U. A. Oparaodu

Department of Ear, Nose and Throat Surgery, Rivers State University Teaching Hospital, Port Harcourt, Nigeria.

G. C. Owhonda

Department of Community Medicine, College of Medical Sciences, Rivers State University, Port Harcourt, Nigeria.

F. E. Aaron

Department of Surgery, Rivers State University, Teaching Hospital, Port Harcourt, Nigeria.

J. R. Inuele

Rivers State Public Health Emergency Operations Center, Rivers State Nigeria.

S. T. Livingstone

Rivers State Public Health Emergency Operations Center, Rivers State Nigeria.

 

View Book :-  https://stm.bookpi.org/CPMS-V6/article/view/7689

Hepatitis B Positivity can Impair Some Haematological Parameters | Chapter 1 | Research Trends and Challenges in Medical Science Vol.4

Hepatitis B virus is a deadly viral infection that kills slowly if not treated and could be the underlying cause of liver cirrhosis and liver cancer. Some Hepatitis B positive patients may present with symptoms while some others maybe asymptomatic hence, the need to assess their haematological indices. Twenty-five Hepatitis B positive patients (male and female) attending Madonna University Teaching Hospital (MUTH) Elele Nigeria were used as subjects while another twenty five Hepatitis B negative apparently healthy individuals (males and females) served as controls. The positive patients were further divided into symptomatic and non-symptomatic groups. Verbal consent was obtained prior to sample collection. The samples were analyzed using standard manual methods. The research was approved by Madonna University Ethical Committee (MUEC). There was significant (p<0.05) decrease in PCV and Hb and while ESR had significant increase. Most of the Hepatitis B positive patients (17) were asymptomatic while others (8) showed symptoms. When the asymptomatic and symptomatic groups were compared, there was no significant (p>0.05) difference in all the parameters. Hepatitis B positive patients could be at risk of developing anaemia. Management and treatment could be better handled before the onset of symptoms associated with Hepatitis B infection. Early diagnosis and inclusion of Hepatitis B screening in routine test is recommended. 

Author(s) Details

 A. O. Ajugwo
Department of Haematology, Madonna University, Elele, Nigeria.

T. A. Erhabor
 Medical Laboratory Science Council of Nigeria (MLSCN), Abuja, Nigeria.

View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/212